fluorides has been researched along with raloxifene hydrochloride in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halbekath, J | 1 |
Kleerekoper, M; Schein, JR | 1 |
Pfeilschifter, J | 2 |
Felsenberg, D; Glüer, CC; Mühlenbacher, D; Nickelsen, T; Pavo, I; Payer, J; Quail, D; Reginster, JY; Resch, H; Schmitt, H; Stepan, J | 1 |
Keck, E | 1 |
2 review(s) available for fluorides and raloxifene hydrochloride
Article | Year |
---|---|
[Drug treatment for the treatment of primary osteoporosis].
Topics: Alendronate; Fluorides; Fractures, Bone; Humans; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D | 2000 |
Comparative safety of bone remodeling agents with a focus on osteoporosis therapies.
Topics: Bone Remodeling; Calcitonin; Calcitriol; Calcium; Diphosphonates; Drug Therapy, Combination; Female; Fluorides; Hormone Replacement Therapy; Humans; Osteoporosis; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators | 2001 |
1 trial(s) available for fluorides and raloxifene hydrochloride
Article | Year |
---|---|
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Topics: Adult; Aged; Analysis of Variance; Anthropometry; Bone Density; Bone Diseases, Metabolic; Double-Blind Method; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
3 other study(ies) available for fluorides and raloxifene hydrochloride
Article | Year |
---|---|
[Risk-adapted therapy of osteoporosis. Preventing fractures].
Topics: Absorptiometry, Photon; Aged; Calcium, Dietary; Cholecalciferol; Diphosphonates; Exercise; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment | 2001 |
[Rational and cost effective osteoporosis prevention and therapy].
Topics: Aged; Cost-Benefit Analysis; Diphosphonates; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2002 |
[Therapy of postmenopausal osteoporosis].
Topics: Activities of Daily Living; Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Antagonists; Estrogens; Exercise; Female; Fluorides; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D; Walking | 2003 |